Morgan Stanley Enzo Biochem Inc Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Enzo Biochem Inc stock. As of the latest transaction made, Morgan Stanley holds 67,342 shares of ENZ stock, worth $37,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,342
Previous 71,855
6.28%
Holding current value
$37,038
Previous $80,000
41.25%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ENZ
# of Institutions
49Shares Held
15.7MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$2.85 Million1.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.37MShares$1.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$1.02 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...